Country sequencing, vendor geography, and QP release chains are strategic decisions made, well or poorly, at the US IND stage, long before a company believes it is ready to think globally.
White Paper
Designing a Global IND Strategy Before You Think You Need One
Related Resources
All Resources
post
Understanding the Phases of FDA Approval for Drug Development
Read More
post
The Next Generation of Regulatory Submissions: Exploring the Benefits of eCTD 4.0
Read More
post
Understanding the Nuances of a Clinical Study Protocol
Read More
post
Why Regulatory Affairs is Important in Drug Approval
Read More
Let's move from science to success.
Let’s Talk